Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sang Jun Yoon

Showing results (81-90 of 86) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 86 results.
Gut Microbes|January 23, 2020
<i>Lactobacillus</i> and <i>Pediococcus</i> ameliorate progression of non-alcoholic fatty liver disease through modulation of the gut microbiomeNa Young Lee, Sang Jun Yoon, Dae Hee Han, et al.
International Journal of Molecular Sciences|July 2, 2021
Diet-Regulating Microbiota and Host Immune System in Liver DiseaseJung A Eom, Goo Hyun Kwon, Na Yeon Kim, et al.
Gut Microbes|February 1, 2024
Gut microbiota-derived indole compounds attenuate metabolic dysfunction-associated steatotic liver disease by improving fat metabolism and inflammationByeong Hyun Min, Shivani Devi, Goo Hyun Kwon, et al.
Clinical and Molecular Hepatology|July 24, 2024
Gut microbiome and metabolome signatures in liver cirrhosis-related complicationsSatya Priya Sharma, Haripriya Gupta, Goo-Hyun Kwon, et al.
Clinical and Translational Medicine|December 29, 2021
Lactobacillus lactis and Pediococcus pentosaceus-driven reprogramming of gut microbiome and metabolome ameliorates the progression of non-alcoholic fatty liver diseaseJeong Seok Yu, Gi Soo Youn, Jieun Choi, et al.
Nature Communications|February 8, 2024
Unraveling the role of the mitochondrial one-carbon pathway in undifferentiated thyroid cancer by multi-omics analysesSeong Eun Lee, Seongyeol Park, Shinae Yi, et al.
Pageof 9

Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
Gut Microbes|January 23, 2020
<i>Lactobacillus</i> and <i>Pediococcus</i> ameliorate progression of non-alcoholic fatty liver disease through modulation of the gut microbiomeNa Young Lee, Sang Jun Yoon, Dae Hee Han, et al.
International Journal of Molecular Sciences|July 2, 2021
Diet-Regulating Microbiota and Host Immune System in Liver DiseaseJung A Eom, Goo Hyun Kwon, Na Yeon Kim, et al.
Gut Microbes|February 1, 2024
Gut microbiota-derived indole compounds attenuate metabolic dysfunction-associated steatotic liver disease by improving fat metabolism and inflammationByeong Hyun Min, Shivani Devi, Goo Hyun Kwon, et al.
Clinical and Molecular Hepatology|July 24, 2024
Gut microbiome and metabolome signatures in liver cirrhosis-related complicationsSatya Priya Sharma, Haripriya Gupta, Goo-Hyun Kwon, et al.
Clinical and Translational Medicine|December 29, 2021
Lactobacillus lactis and Pediococcus pentosaceus-driven reprogramming of gut microbiome and metabolome ameliorates the progression of non-alcoholic fatty liver diseaseJeong Seok Yu, Gi Soo Youn, Jieun Choi, et al.
Nature Communications|February 8, 2024
Unraveling the role of the mitochondrial one-carbon pathway in undifferentiated thyroid cancer by multi-omics analysesSeong Eun Lee, Seongyeol Park, Shinae Yi, et al.
Pageof 9